Joris A. Van Dongen

Dr. Joris A. Van Dongen

University Medical Center Utrecht, Utrecht, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2017 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Open access
PDF file
MSMaroesjka Spiekman
Maroesjka Spiekman
Joris A. Van DongenJoris A. Van Dongen
Joris A. Van Dongen
JWJoep C. Willemsen
Joep C. Willemsen
DHDelia L. Hoppe
Delia L. Hoppe
BLBerend van der Lei
Berend van der Lei
MHMartin Harmsen
Martin Harmsen
Lipofilling or lipografting is a novel and promising treatment method for reduction or prevention of dermal scars after injury. Ample anecdotal evidence from case reports supports the scar-reducing properties of adipose tissue grafts. However, only a few properly controlled and designed clinical trials have been conducted thus far on this topic. Also, the underlying mechanism by which lipofilling improves scar aspect and reduces neuropathic scar pain remains largely undiscovered. Adipose-derived stromal or stem cells (ADSC) are often described to be responsible for this therapeutic effect of lipofilling. We review the recent literature and discuss anticipated mechanisms that govern anti-scarring capacity of adipose tissue and its ADSC. Both clinical and animal studies clearly demonstrated that lipofilling and ADSC influence processes associated with wound healing, including extracellular matrix remodelling, angiogenesis and modulation of inflammation in dermal scars. However, randomized clinical trials, providing sufficient level of evidence for lipofilling and/or ADSC as an anti-scarring treatment, are lacking yet warranted in the near future. © 2017 The Authors Journal of Tissue Engineering and Regenerative Medicine Published by John Wiley & Sons Ltd

21 October 2016 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
Joris A. Van DongenJoris A. Van Dongen
Joris A. Van Dongen
Hieronymus stevensHieronymus stevens
Hieronymus stevens
MPMojtaba Parvizi
Mojtaba Parvizi
BLBerend Van Der Lei
Berend Van Der Lei
MHMartin Harmsen
Martin Harmsen

26 February 2019 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Open access
PDF file
Joris A. Van DongenJoris A. Van Dongen
Joris A. Van Dongen
VGVasilena Getova
Vasilena Getova
LBLinda A. Brouwer
Linda A. Brouwer
GLGabriel R. Liguori
Gabriel R. Liguori
PSPrashant K. Sharma
Prashant K. Sharma
MHMartin Harmsen
Martin Harmsen
Introduction Fat grafting is an established clinical intervention to promote tissue repair. The role of the fat's extracellular matrix (ECM) in regeneration is largely neglected. We investigated in vitro the use of human adipose tissue‐derived ECM hydrogels as release platform for factors secreted by adipose derived stromal cells (ASC) Material & methods Lipoaspirates from non‐diabetic and diabetic donors were decellularized. Finely powdered acellular ECM was evaluated for cell remainders and DNA content. Acellular ECM was digested and hydrogels were formed at 37 °C and their viscoelastic relaxation properties investigated. Release of ASC‐released factors from hydrogels was immune‐assessed and bio‐activity was determined by fibroblast proliferation and migration and endothelial angiogenesis. Results Acellular ECM contained no detectable cell remainders and negligible DNA contents. Viscoelastic relaxation measurements yielded no data for diabetic‐derived hydrogels due to gel instability. Hydrogels released several ASC‐released factors concurrently in a sustained fashion. Functionally, released factors stimulated fibroblast proliferation and migration as well as angiogenesis. No difference between non‐diabetic and diabetic hydrogels in release of factors was measured. Conclusion Adipose ECM hydrogels incubated with released factors by ASC are a promising new therapeutic modality to promote several important wound healing related processes by releasing factors in a controlled way.

9 November 2021 in Skin Research and Technology
Verified
Journal Article
Open access
PDF file
MLMirte Langeveld
Mirte Langeveld
LLLara S. van de Lande
Lara S. van de Lande
ESEimear O’ Sullivan
Eimear O’ Sullivan
BLBerend van der Lei
Berend van der Lei
Joris A. Van DongenJoris A. Van Dongen
Joris A. Van Dongen
Background: Many treatments aim to slow down or reverse the visible signs of skin aging and thereby improve skin quality. Measurement devices are frequently employed to measure the effects of these treatments to improve skin quality, for example, skin elasticity, color, and texture. However, it remains unknown which of these devices is most reliable and valid.Materials and methods: MEDLINE, Embase, Cochrane Central, Web of Science, and Google Scholar databases were searched. Instruments were scored on reporting construct validity by means of convergent validity, interobserver, intraobserver, and interinstrument reliability.Results: For the evaluation of skin color, 11 studies were included describing 16 measurement devices, analyzing 3172 subjects. The most reliable device for skin color assessment is the Minolta Chromameter CR‐300 due to good interobserver, intraobserver, and interinstrument reliability. For skin elasticity, seven studies assessed nine types of devices analyzing 290 subjects in total. No intra and interobserver reliability was reported. Skin texture was assessed in two studies evaluating 72 subjects using three different types of measurement devices. The PRIMOS device reported excellent intra and interobserver reliability. None of the included reviewed devices could be determined to be valid based on construct validity.Conclusion: The most reliable devices to evaluate skin color and texture in ordinary skin were, respectively, the Minolta Chromameter and PRIMOS. No reliable device is available to measure skin elasticity in ordinary skin and none of the included devices could be determined to be designated as valid.

29 May 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
GLGabriel Romero Liguori
Gabriel Romero Liguori
TLTácia Tavares Aquinas Liguori
Tácia Tavares Aquinas Liguori
SMSérgio Rodrigues de Moraes
Sérgio Rodrigues de Moraes
VSViktor Sinkunas
Viktor Sinkunas
VTVincenzo Terlizzi
Vincenzo Terlizzi
MHMartin Harmsen
Martin Harmsen
Decellularized-organ-derived extracellular matrix (dECM) has been used for many years in tissue engineering and regenerative medicine. The manufacturing of hydrogels from dECM allows to make use of the pro-regenerative properties of the ECM and, simultaneously, to shape the material in any necessary way. The objective of the present project was to investigate differences between cardiovascular tissues (left ventricle, mitral valve, and aorta) with respect to generating dECM hydrogels and their interaction with cells in 2D and 3D. The left ventricle, mitral valve, and aorta of porcine hearts were decellularized using a series of detergent treatments (SDS, Triton-X 100 and deoxycholate). Mass spectrometry-based proteomics yielded the ECM proteins composition of the dECM. The dECM was digested with pepsin and resuspended in PBS (pH 7.4). Upon warming to 37°C, the suspension turns into a gel. Hydrogel stiffness was determined for samples with a dECM concentration of 20 mg/mL. Adipose tissue-derived stromal cells (ASC) and a combination of ASC with human pulmonary microvascular endothelial cells (HPMVEC) were cultured, respectively, on and in hydrogels to analyze cellular plasticity in 2D and vascular network formation in 3D. Differentiation of ASC was induced with 10 ng/mL of TGF-β1 and SM22α used as differentiation marker. 3D vascular network formation was evaluated with confocal microscopy after immunofluorescent staining of PECAM-1. In dECM, the most abundant protein was collagen VI for the left ventricle and mitral valve and elastin for the aorta. The stiffness of the hydrogel derived from the aorta (6,998 ± 895 Pa) was significantly higher than those derived from the left ventricle (3,384 ± 698 Pa) and the mitral valve (3,233 ± 323 Pa) (One-way ANOVA, p = 0.0008). Aorta-derived dECM hydrogel drove non-induced (without TGF-β1) differentiation, while hydrogels derived from the left ventricle and mitral valve inhibited TGF-β1-induced differentiation. All hydrogels supported vascular network formation within 7 days of culture, but ventricular dECM hydrogel demonstrated more robust vascular networks, with thicker and longer vascular structures. All the three main cardiovascular tissues, myocardium, valves, and large arteries, could be used to fabricate hydrogels from dECM, and these showed an origin-dependent influence on ASC differentiation and vascular network formation.

7 May 2019 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Open access
VGVasilena E. Getova
Vasilena E. Getova
Joris A. Van DongenJoris A. Van Dongen
Joris A. Van Dongen
LBLinda A. Brouwer
Linda A. Brouwer
MHMartin Harmsen
Martin Harmsen
Adipose tissue has the therapeutic capacity in the form of a fat graft, for example, for treatment of irradiation-induced scars and difficult to heal dermal wounds. For large-scale clinical application, an off-the-shelf product is warranted. In recent years, ECM-derived hydrogels are postulated to harbour therapeutic capacity and might even replicate the beneficial effects of adipose tissue. In normal homeostasis, the natural ECM acts as a deposit of growth factors, that releases them over time. In the healing of lesions, this might promote cell accumulation and proliferation which in turn stimulates angiogenesis and repair. The decellularization of tissue and the generation of hydrogels may leave cytotoxic traces. Therefore, our research assessed the cytotoxic effect of human adipose tissue-derived ECM hydrogels on connective tissue cells i.e. fibroblasts. The results showed no cytotoxicity, meaning the hydrogels caused no cell death. Cell migration and survival were observed when cultured in ECM hydrogels and followed for 7 days. Cell survival in the hydrogel was confirmed with CFDA staining and also cells showed the ability to penetrate and migrate throughout the gel. We conclude that ECM hydrogels are promising to use as innovative therapy for wound healing.